London
A new pain reliever that uses marijuana extracts can be prescribed in Britain, the government said this week. Under the new policy, the drug Sativex can be given to multiple sclerosis patients to relieve pain and spasms. For now, British patients must import their Sativex from Canada. But GW Pharmaceuticals, the company that makes Sativex, has been given a license to cultivate pot in the U.K. and plans to open a factory there. The plants are already being grown at a secret location somewhere in England.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
The FDA plans to embrace AI agencywideIn the Spotlight Rumors are swirling about a bespoke AI chatbot being developed for the FDA by OpenAI
-
Digital consent: Law targets deepfake and revenge pornFeature The Senate has passed a new bill that will make it a crime to share explicit AI-generated images of minors and adults without consent
-
Will Republicans tax the rich?Today's Big Question Trump is waffling on the possibility of taxing wealthy earners
